India, Aug. 15 -- image credit- shutterstock

Laborate Pharmaceuticals, one of India's leading pharmaceutical manufacturing and export companies,is currently in advanced discussions with partners in the EU and UK for theco-development and commercial supply of finished formulations, with projected international revenue growth of over $100 million over the next five years.

The company recently announced that its manufacturing site inLaborate Pharmaceuticals India Ltd, 111, Paonta Sahib, ( HP)has been granted theEU-GMP (European Union - Good Manufacturing Practice)certification from the relevant European regulatory agency.

The facility certification provides a path to filing regulatory dossiers for multiple products in the EU market. The c...